WHO Selects International Nonproprietary Name for Percheron Therapeutics' Drug Candidate ATL1102
WHO Selects International Nonproprietary Name for Percheron Therapeutics' Drug Candidate ATL1102
世衛組織爲 Percheron Therapeutics 的候選藥物 ATL1102 選擇國際非專利名稱
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊